PRECIPIO, INC. Gain (Loss) Related to Litigation Settlement
PRECIPIO, INC. (PRPO) reported Gain (Loss) Related to Litigation Settlement of $25.00 thousand for the 12-month period ending 2022-12-31, per its 10-K filed 2024-03-29.
Discontinued › Income Statement › Other Income
us-gaap:GainLossRelatedToLitigationSettlement · last filed 2024-03-29
- PRECIPIO, INC. gain (loss) related to litigation settlement for the quarter ending 2022-12-31 was $21.00K, a 250.00% increase year-over-year.
- PRECIPIO, INC. gain (loss) related to litigation settlement for the quarter ending 2022-09-30 was $3.00K, a 76.92% decline year-over-year.
- PRECIPIO, INC. gain (loss) related to litigation settlement for the quarter ending 2022-06-30 was $0.00, a 100.00% decline year-over-year.
- PRECIPIO, INC. gain (loss) related to litigation settlement for the quarter ending 2022-03-31 was $1.00K, a 94.12% decline year-over-year.
- PRECIPIO, INC. gain (loss) related to litigation settlement for fiscal 2022 was $25.00K, a 52.83% decline from fiscal 2021.
- PRECIPIO, INC. gain (loss) related to litigation settlement for fiscal 2021 was $53.00K, a 31.17% decline from fiscal 2020.
- PRECIPIO, INC. gain (loss) related to litigation settlement for fiscal 2020 was $77.00K, a 94.64% decline from fiscal 2019.
- PRECIPIO, INC. gain (loss) related to litigation settlement for fiscal 2019 was $1.44M, a 446.39% increase from fiscal 2018.
| Period end | Gain (Loss) Related to Litigation Settlement 3 month | Gain (Loss) Related to Litigation Settlement 6 month | Gain (Loss) Related to Litigation Settlement 9 month | Gain (Loss) Related to Litigation Settlement 12 month |
|---|---|---|---|---|
| 2022-12-31 | $21.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | $24.00K derived: sum of 2 quarters · filed 2024-03-29 | $24.00K derived: sum of 3 quarters · filed 2024-03-29 | $25.00K 10-K · filed 2024-03-29 |
| 2022-09-30 | $3.00K 10-Q · filed 2023-11-13 | $3.00K derived: sum of 2 quarters · filed 2023-11-13 | $4.00K 10-Q · filed 2023-11-13 | $10.00K derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-11 | $1.00K 10-Q · filed 2023-08-11 | $7.00K derived: sum of 3 quarters · filed 2023-08-11 | $20.00K derived: sum of 4 quarters · filed 2023-08-11 |
| 2022-03-31 | $1.00K 10-Q · filed 2023-05-12 | $7.00K derived: sum of 2 quarters · filed 2023-05-12 | $20.00K derived: sum of 3 quarters · filed 2023-05-12 | $37.00K derived: sum of 4 quarters · filed 2023-05-12 |
| 2021-12-31 | $6.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $19.00K derived: sum of 2 quarters · filed 2023-03-30 | $36.00K derived: sum of 3 quarters · filed 2023-03-30 | $53.00K 10-K · filed 2023-03-30 |
| 2021-09-30 | $13.00K 10-Q · filed 2022-11-10 | $30.00K derived: sum of 2 quarters · filed 2022-11-10 | $47.00K 10-Q · filed 2022-11-10 | $124.00K derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | $17.00K 10-Q · filed 2022-08-11 | $34.00K 10-Q · filed 2022-08-11 | $111.00K derived: sum of 3 quarters · filed 2022-08-11 | $111.00K derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | $17.00K 10-Q · filed 2022-05-11 | $94.00K derived: sum of 2 quarters · filed 2022-05-11 | $94.00K derived: sum of 3 quarters · filed 2022-05-11 | $94.00K derived: sum of 4 quarters · filed 2022-05-11 |
| 2020-12-31 | $77.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | $77.00K derived: sum of 2 quarters · filed 2022-03-30 | $77.00K derived: sum of 3 quarters · filed 2022-03-30 | $77.00K 10-K · filed 2022-03-30 |
| 2020-09-30 | $0.00 10-Q · filed 2020-11-13 | $0.00 derived: sum of 2 quarters · filed 2020-11-13 | $0.00 10-Q · filed 2020-11-13 | |
| 2020-06-30 | $0.00 10-Q · filed 2020-08-13 | $0.00 10-Q · filed 2020-08-13 | ||
| 2019-12-31 | $186.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-29 | $186.00K derived: sum of 2 quarters · filed 2021-03-29 | $1.27M derived: sum of 3 quarters · filed 2021-03-29 | $1.44M 10-K · filed 2021-03-29 |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-13 | $1.08M derived: sum of 2 quarters · filed 2020-11-13 | $1.25M 10-Q · filed 2020-11-13 | $1.30M derived: sum of 4 quarters · filed 2020-11-13 |
| 2019-06-30 | $1.08M 10-Q · filed 2020-08-13 | $1.25M 10-Q · filed 2020-08-13 | $1.30M derived: sum of 3 quarters · filed 2020-08-13 | $1.37M derived: sum of 4 quarters · filed 2020-08-13 |
| 2019-03-31 | $167.00K 10-Q · filed 2020-05-14 | $217.00K derived: sum of 2 quarters · filed 2020-05-14 | $283.00K derived: sum of 3 quarters · filed 2020-05-14 | $289.00K derived: sum of 4 quarters · filed 2020-05-14 |
| 2018-12-31 | $50.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-27 | $116.00K derived: sum of 2 quarters · filed 2020-03-27 | $122.00K derived: sum of 3 quarters · filed 2020-03-27 | $263.00K 10-K · filed 2020-03-27 |
| 2018-09-30 | $66.00K 10-Q · filed 2019-11-13 | $72.00K derived: sum of 2 quarters · filed 2019-11-13 | $213.00K 10-Q · filed 2019-11-13 | $443.00K derived: sum of 4 quarters · filed 2019-11-13 |
| 2018-06-30 | $6.00K 10-Q · filed 2019-08-09 | $147.00K 10-Q · filed 2019-08-09 | $377.00K derived: sum of 3 quarters · filed 2019-08-09 | $1.02M derived: sum of 4 quarters · filed 2019-08-09 |
| 2018-03-31 | $141.00K 10-Q · filed 2019-05-16 | $371.00K derived: sum of 2 quarters · filed 2019-05-16 | $1.02M derived: sum of 3 quarters · filed 2019-05-16 | |
| 2017-12-31 | $230.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-16 | $877.00K derived: sum of 2 quarters · filed 2019-04-16 | $877.00K 10-K · filed 2019-04-16 | |
| 2017-09-30 | $647.00K 10-Q · filed 2018-11-19 | $647.00K 10-Q · filed 2018-11-19 | ||
| 2016-09-30 | $0.00 10-Q · filed 2017-11-20 | $0.00 10-Q · filed 2017-11-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |